Immune heparin-induced thrombocytopenia resulting from preceding exposure to heparin catheter flushes

被引:24
作者
Muslimani, Alaa A.
Ricalurte, Basma
Daw, Hamed A.
机构
[1] Cleveland Clin, Ctr Canc, Cleveland, OH 44111 USA
[2] Fairview Hosp, Cleveland Clin Hlth Syst, Dept Internal Med, Cleveland, OH USA
关键词
heparin catheter flashes; rapid-onset heparin induced thrombocytopenia; UNFRACTIONATED HEPARIN; PATHOGENESIS; ANTIBODIES; MANAGEMENT; DIAGNOSIS; COMPLEXES;
D O I
10.1002/ajh.20849
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Immune heparin-induced thrombocytopenia (HIT) is a life-threatening adverse effect of heparin. It can result from any type of heparin exposure and by any route of administration; however only a few cases are reported after exposures to small quantities of heparin from catheter flushes. The major clinical problem associated with HIT is thrombosis. Early detection and institution of alternative, non-heparin anticoagulation are important. We report a patient with HIT associated with use of therapeutic-dose unfractionated heparin in whom immune sensitization to heparin was triggered by two 500-unit exposure to UFH associated with intravascular catheter flushing for antineoplastic chemotherapy in a patient with colon adenocarcinoma.
引用
收藏
页码:652 / 655
页数:4
相关论文
共 23 条
[1]   How I treat heparin-induced thrombocytopenia and thrombosis [J].
Alving, BM .
BLOOD, 2003, 101 (01) :31-37
[2]  
Blank M, 1999, SEMIN HEMATOL, V36, P12
[3]   Titre of anti-heparin/PF4-antibodies and extent of in vivo activation of the coagulation and fibrinolytic systems [J].
Chilver-Stainer, L ;
Lämmle, B ;
Alberio, L .
THROMBOSIS AND HAEMOSTASIS, 2004, 91 (02) :276-282
[4]   Fondaparinux for thromboembolic treatment and prophylaxis of heparin-induced thrombocytopenia [J].
Efird, Leigh E. ;
Kockler, Denise R. .
ANNALS OF PHARMACOTHERAPY, 2006, 40 (7-8) :1383-1387
[5]   Heparin-induced thrombocytopenia in neurologic disease treated with unfractionated heparin [J].
Harbrecht, U ;
Bastians, B ;
Kredteck, A ;
Hanfland, P ;
Klockgether, T ;
Pohl, C .
NEUROLOGY, 2004, 62 (04) :657-659
[6]   Heparin-induced thrombocytopenia (HIT) due to heparin flushes: a report of three cases [J].
Kadidal, VV ;
Mayo, DJ ;
Horne, MK .
JOURNAL OF INTERNAL MEDICINE, 1999, 246 (03) :325-329
[7]  
Kelton JG, 1995, AM J CLIN PATHOL, V104, P611
[8]   Stroke in patients with heparin-induced thrombocytopenia and the effect of argatroban therapy [J].
LaMonte, MP ;
Brown, PM ;
Hursting, MJ .
CRITICAL CARE MEDICINE, 2004, 32 (04) :976-980
[9]   Serologic evidence of heparin sensitization in cancer patients receiving heparin flushes of venous access devices [J].
Mayo, DJ ;
Cullinane, AM ;
Merryman, PK ;
Horne, MK .
SUPPORTIVE CARE IN CANCER, 1999, 7 (06) :425-427
[10]   Induction of monocyte tissue factor expression by antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopenia [J].
Pouplard, C ;
Iochmann, S ;
Renard, B ;
Herault, O ;
Colombat, P ;
Amiral, J ;
Gruel, Y .
BLOOD, 2001, 97 (10) :3300-3302